Direct Discrimination of Quantum States by the Human Eye

Sponsor
Centre for Eye and Vision Research (Other)
Overall Status
Recruiting
CT.gov ID
NCT05913063
Collaborator
University of Waterloo (Other), The Hong Kong Polytechnic University (Other)
50
1
1
15.2
3.3

Study Details

Study Description

Brief Summary

Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.

Condition or Disease Intervention/Treatment Phase
  • Device: Structured Light Imaging Microscopy
N/A

Detailed Description

There has been tremendous progress in generating and detecting structured light which possesses advantageous propagation characteristics such as quantized orbital angular momentum (OAM), non-diffraction, and self-healing. These special beams have found applications in microscopy, encoding and multiplexing of communications, and manipulation of matter. Here the investigators bring the structured light toolbox to vision sciences for the first time and expand the space of possible stimuli.

A healthy macula possesses azimuthally ordered dichroic fibres that act as a radial polarization filter, enabling a typical person to perceive linearly polarized light through the entoptic phenomena known as Haidinger's brushes. Despite significant interest in the application of this phenomenon to the detection of age-related macular degeneration, no device has currently seen widespread adoption in a clinical environment. This is due to the difficulty in observing Haidinger's brush, the imprecise measurements that this test can extract, and the difficulty in instructing patients during these tests.

Leveraging the quantum-inspired toolbox developed in the field of structured light, the investigators can project polarization-coupled OAM states of light directly on a person's retina. This enables the investigators to create arbitrary entoptic patterns in a person's vision based on the structure and chemical composition of their subjective macula, and the investigators have the opportunity to develop a litany of novel diagnostic tests to characterize and quantify the health of the macula.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Within-subject, measuring the threshold SL-based entoptic phenomenon circular obstruction size of the radial retinal polarizerWithin-subject, measuring the threshold SL-based entoptic phenomenon circular obstruction size of the radial retinal polarizer
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Direct Discrimination of Quantum States by the Human Eye With Macular Degeneration
Actual Study Start Date :
Jun 26, 2023
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Participants with Age-Related Macular Degeneration

Conducting the psychophysical task on the perception of OAM-coupled polarized light

Device: Structured Light Imaging Microscopy
Conducting the psychophysical task on the perception of OAM-coupled polarized light created using the experimental setup - Structured Light Imaging Microscopy (SLIM). Four types of vortex orbital angular momentum, differing by the number of fringes l=5;10; 15;20, will be presented for 0.5s per trial during which an azimuthally varying entoptic profile rotated clockwise or counterclockwise. A circular mask with a varying radius will be placed at fixation, thus the task will be performed at varying eccentricities. Circular obstruction of the area will be achieved due to the high refresh-rate structured light modulator. The threshold mask size will be changed by a 2up/1down staircase method (71% accuracy for the estimation of mask size).

Outcome Measures

Primary Outcome Measures

  1. Perception of the structured light [Approximately 10 minutes, Screening and Training day (Session 1)]

    Assessment of the participant's ability to see the entoptic phenomena created using the structured light (SL) - orbital angular momentum (OAM) coupled polarized light. Various SL vortex and radial patterns will be projected using the custom research-based laser optical setup

  2. Radius of the radial retinal polarizer [Approximately 30 minutes, on the completion of the study (Session 6)]

    Calculation of the radius of the central obstruction. From a total of 14 reversal trials, the six last values of the mask size will be used for the calculation of the threshold mask size mean (r mean). The standard deviation will be computed from the variance of these last six trials

Secondary Outcome Measures

  1. Thickness of retina and retinal layers [Approximately 10 minutes, Screening and Training day (Session 1)]

    Measurement of the retinal layers' thickness and total neuroretina

  2. Contrast sensitivity [Approximately 5 minutes, Screening and Training day (Session 1)]

    Computer-based measurement of contrast sensitivity

  3. Fundus photography [Approximately 5 minutes, Screening and Training day (Session 1)]

    Imaging the retina using white light. The diameter of the optic nerve head will be measured in order to calculate the degree/pixel ratio for each participant

  4. Ocular biometry measurement [Approximately 5 minutes, Screening and Training day (Session 1)]

    Measurement of the central corneal thickness and axial eye length

  5. Macular pigment optical density measurement [Approximately 10 minutes, Screening and Training day (Sessions 1 and 2)]

    Computer-based measurement of the macular pigment optical density (MPOD)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Participants who are clinically diagnosed with a vision disease affecting their macula

  • Older adults who are matched for age.

  • Participants who are clinically diagnosed with glaucoma

  • Participants who have normal vision.

  • One aged-matched control with normal vision will be recruited for each of the diagnosed groups (born in the same year).

Exclusion Criteria:
  • Participants with any additional eye diagnosis or condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre for Eye and Vision Research Limited Hong Kong Guangdong Hong Kong 00000

Sponsors and Collaborators

  • Centre for Eye and Vision Research
  • University of Waterloo
  • The Hong Kong Polytechnic University

Investigators

  • Principal Investigator: Benjamin Thompson, PhD, Centre for Eye and Vision Research
  • Study Director: Mukhit Kulmaganbetov, MD, PhD, Centre for Eye and Vision Research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre for Eye and Vision Research
ClinicalTrials.gov Identifier:
NCT05913063
Other Study ID Numbers:
  • SLIM
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 27, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre for Eye and Vision Research
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 27, 2023